A microbiology analyzer is an instrument which allows to measure microbes or different characteristics in any given specimen. Automation level has been lagging in the field of microbiology as compared to other fields because it still remains labor intensive. This is reason the data quality is hampered by isolated systems and the transferring process. Recently, it has been observed that there are several advances in semi-automated and automated technology in the field of microbiology analyzers.
Advancement in technologies and increase in pressure to deliver the results faster have led to increase in use of microbiology analyzers. These semi-automated and automated analyzers have high accuracy, repeatability, and less labor requirement leading toward higher growth of the microbiology analyzers and consumables market. In addition, other factors such as short duration, flexibility, and low volume of specimen required have resulted in increase use of analyzers. The laboratories using the analyzers need huge investment which may restrain the market growth during the forecast period.
The microbiology analyzers and consumables market can be segmented into product, application, specimen, end-user, and geography. In terms of product, the market is further segmented into mass spectrophotometers, microscopes, molecular diagnostic instruments, and others. With respect to application, the market is divided into microbial identification, antibiotic susceptibility, urine screening, and blood cultures. In terms of specimen, the market is segmented into urine, sterile fluids, blood, serum, CSF, throat swabs, respiratory secretions, genital secretions, stool, abscess/wound, sputum, and saliva. In terms of end-user, the market is divided into pharmaceuticals, research laboratories, diagnostic laboratories, and others.
Geographically, the microbiology analyzer and consumables market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East Asia & Africa. North America held a large market share due to high investments, technological modifications, and increase in demand for automation, which is then followed by Europe. Furthermore, the factors contributing to the growth of the market are need for speedy microbiological testing, emergence, increase in number of mutating microorganism, and prevalence of pathogenic diseases. The emerging economies such as Asia Pacific and Latin America are expected to show tremendous growth owing to increase in the number of laboratories and development of instrumentation systems. Rise in number of hospital chains in major cities of these regions and high government investment in health care are key factors driving the growth of the market.
Key player operating in the market include Abbott, Affymetrix, Agilent Technologies, Applied Gene Technologies, Arca Biopharma, Beckman Coulter/Danaher, Becton Dickinson, Biokit, bioMerieux, Bio-Rad, Li-Cor Biosciences, Lonza, Monogram Biosciences, Myriad Genetics,Ortho-Clinical Diagnostics, Perkin Elmer/Caliper, Proteome Sciences, Qiagen, Roche, Scienion, Sequenom, SeraCare, Shimadzu, Siemens, Tecan, Sierra Molecular, Takara Bio, and Thermo Fisher, Wallac/PE. Companies are focusing on strategic approaches such as mergers & acquisitions, collaborations, new product launches, and free workshops for better awareness to maintain a significant position in the global market. For example, in 2015, bioMerieux signed a collaborative agreement with COPAN for distribution rights of WASP and WASP lab solution, which enhances automation and efficiency in microbiology laboratories.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.